APRINOIA Therapeutics Inc. (APRI)
APRINOIA Therapeutics was planning to go public, but the IPO was withdrawn on Oct 28, 2024.
IPO Price Range
$10.00 - $12.00
Shares Offered
500,000
Deal Size
$5.50M
APRINOIA Therapeutics Revenue
APRINOIA Therapeutics had revenue of $9.13M in the twelve months ending June 30, 2023. In the year 2022, APRINOIA Therapeutics had annual revenue of $394.00K, down -28.36%.
Revenue (ttm)
$9.13M
Revenue Growth
-28.36%
P/S Ratio
32.35
Revenue / Employee
$126,847
Employees
72
Market Cap
295.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 394.00K | -156.00K | -28.36% |
| Dec 31, 2021 | 550.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionAPRI News
- 1 year ago - Aprinoia Therapeutics Starts $50 Million IPO For Neurodegenerative Disease Treatments - Seeking Alpha
- 1 year ago - Clinical-Stage Biotech Aprinoia Therapeutics Files for IPO - MarketWatch
- 1 year ago - APRINOIA Therapeutics IPO Registration Document (F-1) - SEC